Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Lucchesi

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 22, 2018
Molecular determinants of acquired resistance to BRAF inhibition in human lung cancerCarlo Lucchesi, Benjamin Drogat, David Santamaria, et al.
Biomarker Research|July 23, 2020
Inactivating mutations in genes encoding for components of the BAF/PBAF complex and immune-checkpoint inhibitor outcomeKevin Courtet, Yec'han Laizet, Carlo Lucchesi, et al.
Nature Genetics|June 28, 2008
ESR1 gene amplification in breast cancer: a common phenomenon?Anne Vincent-Salomon, Virginie Raynal, Carlo Lucchesi, et al.
Oncotarget|December 22, 2016
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implicationsBenjamin Fourneaux, Vanessa Chaire, Carlo Lucchesi, et al.
JAMA Oncology|May 26, 2018
Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized TherapyCarlo Lucchesi, Emmanuel Khalifa, Yec'han Laizet, et al.
Genes, Chromosomes & Cancer|June 17, 2008
Characterization of amplicons in neuroblastoma: high-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genesAnne Fix, Carlo Lucchesi, Agnès Ribeiro, et al.
Journal of Hematology & Oncology|April 13, 2017
Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomasAudrey Laroche, Vanessa Chaire, François Le Loarer, et al.
Cancer Communications (London, England)|February 8, 2022
Gene expression profiling improves prognostication by nomogram in patients with soft-tissue sarcomasAmandine Crombé, Mariella Spalato-Ceruso, Audrey Michot, et al.
Nature Genetics|March 6, 2012
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusionGaëlle Pierron, Franck Tirode, Carlo Lucchesi, et al.
European Radiology|August 27, 2022
Distinct patterns of the natural evolution of soft tissue sarcomas on pre-treatment MRIs captured with delta-radiomics correlate with gene expression profilesAmandine Crombé, Frédéric Bertolo, David Fadli, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|October 22, 2018
Molecular determinants of acquired resistance to BRAF inhibition in human lung cancerCarlo Lucchesi, Benjamin Drogat, David Santamaria, et al.
Biomarker Research|July 23, 2020
Inactivating mutations in genes encoding for components of the BAF/PBAF complex and immune-checkpoint inhibitor outcomeKevin Courtet, Yec'han Laizet, Carlo Lucchesi, et al.
Nature Genetics|June 28, 2008
ESR1 gene amplification in breast cancer: a common phenomenon?Anne Vincent-Salomon, Virginie Raynal, Carlo Lucchesi, et al.
Oncotarget|December 22, 2016
Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implicationsBenjamin Fourneaux, Vanessa Chaire, Carlo Lucchesi, et al.
JAMA Oncology|May 26, 2018
Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized TherapyCarlo Lucchesi, Emmanuel Khalifa, Yec'han Laizet, et al.
Genes, Chromosomes & Cancer|June 17, 2008
Characterization of amplicons in neuroblastoma: high-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genesAnne Fix, Carlo Lucchesi, Agnès Ribeiro, et al.
Journal of Hematology & Oncology|April 13, 2017
Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomasAudrey Laroche, Vanessa Chaire, François Le Loarer, et al.
Cancer Communications (London, England)|February 8, 2022
Gene expression profiling improves prognostication by nomogram in patients with soft-tissue sarcomasAmandine Crombé, Mariella Spalato-Ceruso, Audrey Michot, et al.
Nature Genetics|March 6, 2012
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusionGaëlle Pierron, Franck Tirode, Carlo Lucchesi, et al.
European Radiology|August 27, 2022
Distinct patterns of the natural evolution of soft tissue sarcomas on pre-treatment MRIs captured with delta-radiomics correlate with gene expression profilesAmandine Crombé, Frédéric Bertolo, David Fadli, et al.
Pageof 5